Bassler Bonnie L
SEC Form 4 insider trading activity
Bassler Bonnie L has filed 9 SEC Form 4 filings (11 transaction rows) across 3 companies, including RPRX, REGN, CDTX, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.
On the most recent filing, Bassler Bonnie L is listed as Director at REGENERON PHARMACEUTICALS, INC. Inside the rolling window, Bassler Bonnie L reported no open-market purchases and 2 open-market sales totaling $1.8M in REGN. The largest disclosed transaction in the window is a sale of 1,500 REGN shares on Jan 7, 2026, worth $1.2M.
Companies traded
Other insiders at RPRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.8M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bassler Bonnie L made?
Bassler Bonnie L has filed 9 SEC Form 4 filings (11 transaction rows) across 3 companies, including RPRX, REGN, CDTX since 2025.
Which companies does Bassler Bonnie L trade?
Bassler Bonnie L has filed SEC Form 4 disclosures for 3 companies, including RPRX, REGN, CDTX.
When was Bassler Bonnie L's most recent SEC Form 4 filing?
Bassler Bonnie L's most recent SEC Form 4 filing on Tracefour is dated Jun 30, 2026.
What is Bassler Bonnie L's total buy and sell value in the current window?
Inside the rolling retention window, Bassler Bonnie L bought $0 and sold $1.8M based on SEC Form 4 filings.
What was Bassler Bonnie L's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,500 REGN shares on 2026-01-07, worth $1.2M, per SEC Form 4 filings.